
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services Inc. has demonstrated strong financial performance, with the Acute Care Hospital Services segment achieving a substantial adjusted EBITDA margin expansion of 190 basis points to 15.8%. The company reported an impressive 12.8% year-over-year growth in same-store revenue for the acute segment, driven by an increase in patient day growth and revenue per adjusted admission. Furthermore, anticipated benefits from pending CMS programs, along with expected margin improvements due to easing labor and cost pressures, contribute to a favorable outlook for the company's future earnings growth.
Bears say
The negative outlook on Universal Health Services Inc. stems from projected earnings that are expected to be approximately 5% lower than earlier estimates, influenced by volume and margin headwinds. Additionally, the company's long-term behavioral volume growth forecast has been adjusted downward, which could negatively impact anticipated EBITDA contributions, especially with projections indicating a significant decline starting in 2028. Furthermore, risks such as potential regulatory changes, high market concentration, and tight clinical labor supply are likely to exacerbate pressures on productivity and margins across the company's segments.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares